Early studies have shown that upregulated expression of ASNS could be related to the resistance of leukemia cells to L-aspartase, which is widely used as an active component in the treatment of pediatric acute lymphocytic leukaemia and some types of acute myeloid leukaemia (Zwaan et al., 2002). The gene discussed is ASNS; the disease is acute lymphoblastic leukemia.